Back to search

Article

CRY1 fuels resistance to T cell-based immunotherapy in NANOGhigh cancers

2025-01-08

Abstract excerpt

<title>Abstract</title> <p> Cancer immunotherapies, including immune checkpoint blockade (ICB), have marked a significant breakthrough in cancer treatment but their clinical efficacy is limited in immune-resistant tumors. Previously, we found that immunotherapy-mediated immune selection enriches immune-resistant tumors with both tumor-intrinsic and -extrinsic refractory phenotypes via the transcriptional inducti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0ed957e1-dd76-58f6-bd83-9f36364de27f
DOI
10.21203/rs.3.rs-5658722/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRY1 fuels resistance to T cell-based immunotherapy in NANOGhigh cancersDOI 10.21203/rs.3.rs-5658722/v1
Select a neighboring publication to make it the new centre.